Growth and endocrine function following bone marrow transplantation for thalassemia major

Pediatric Hematology and Oncology

Volumn 21, Issue 5, 2004, Pages 411-419

  Li, Chi Kong ^a   Chik, Ki Wai ^a   Wong, Gary Wing Kin ^a   Cheng, Pik Shun ^a   Lee, Vincent ^a   Shing, Matthew Ming Kong ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Endocrine function; Growth; Thalassemia major

Indexed keywords

GONADOTROPIN; SEX HORMONE;

ADOLESCENT; ARTICLE; BODY HEIGHT; BONE MARROW TRANSPLANTATION; CHILD; CHILD GROWTH; CLINICAL ARTICLE; DIABETES MELLITUS; ENDOCRINE DISEASE; ENDOCRINE FUNCTION; FEMALE; FOLLOW UP; GONAD DYSFUNCTION; GROWTH HORMONE DEFICIENCY; GROWTH RETARDATION; HORMONE SUBSTITUTION; HUMAN; MALE; OVARY INSUFFICIENCY; PUBERTY; SURVIVAL; THALASSEMIA MAJOR;

ADOLESCENT; BETA-THALASSEMIA; BONE MARROW TRANSPLANTATION; CHILD; CHILD DEVELOPMENT; ENDOCRINE SYSTEM; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; GROWTH DISORDERS; HUMANS; MALE; PROSPECTIVE STUDIES; PUBERTY, DELAYED;

EID: 3042766492     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/08880010490457132     Document Type: Article

References (16)

1. Borgna-Pignatti C, De Stefano P, Zonta L, et al. Growth and sexual maturation in thalassemia major. J Pediatr. 1985;106:150-155.
2. De Sanctis V, Pinamonti A, Di Palma A, et al. Growth and development in thalassaemia major patients with severe bone lesions due to desferrioxamine. Eur J Pediatr. 1996;155:368-372.
3. Li CK, Lai DH, Shing MMK, et al. Early iron reduction programme for thalassaemia patients after bone marrow transplantation. Bone Marrow Transplant. 2000;25:653-656.
4. Wingard JR, Plotnick LP, Freemer CS, et al. Growth in children after bone marrow transplantation: busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation. Blood. 1992;79:1068-1073.
5. Michel G, Socie G, Gebhard F, et al. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation-a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol. 1997;15:2238-2246.
6. Leung SS, Lau JT, Xu YY, et al. Secular changes in standing height, sitting height and sexual maturation of Chinese-the Hong Kong Growth Study, 1993. Ann Hum Biol. 1996;23:297-306.
7. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child. 1976;51:170-179.
8. Italian Working Group on Endocrine Complications in Non-endocrine Diseases. Multicentre study on prevalence of endocrine complications in thalassaemia major. Clin Endocrinol. 1995;42:581-586.
9. Huma Z, Boulad F, Black P, et al. Growth in children after bone marrow transplantation for acute leukemia. Blood. 1995;86:819-824.
10. Sanders JE, Buckner CD, Sullivan KM, et al. Growth and development in children after bone marrow transplantation. Horm Res. 1988;30:92-97.
11. Shankar SM, Bunin NJ, Moshang T Jr. Growth in children undergoing bone marrow transplantation after busulfan and cyclophosphamide conditioning. J Pediatr Hematol Oncol. 1996;18:362-366.
12. Afify Z, Shaw PJ, Clavano-Harding A, et al. Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide. Bone Marrow Transplant. 2000;25:1087-1092.
13. Gaziev J, Galimberti M, Giardini C, et al. Growth in children after bone marrow transplantation for thalassemia. Bone Marrow Transplant. 1993;12(S1):100-101.
14. De Simone M, Olioso P, Di Bartolomeo P, et al. Growth and endocrine function following bone marrow transplantation for thalassemia. Bone Marrow Transplant. 1995;15:227-233.
15. Teinturier C, Hartmann O, Valteau-Couanet D, et al. Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure. Bone Marrow Transplant. 1998;22:989-994.
16. Mertens AC, Ramsay NKC, Kouris S, et al. Patterns of gonadal dysfunction following bone marrow transplantation. Bone Marrow Transplant. 1998;22:345-350.